| Harry Lee Spurling, MA LMFT LPCMHSP LSPE | |
|
109 W Watauga Ave, Johnson City, TN 37604 | |
| (423) 232-2700 | |
| (423) 232-2714 |
| Full Name | Harry Lee Spurling |
|---|---|
| Gender | Male |
| Speciality | Counselor - Professional |
| Location | 109 W Watauga Ave, Johnson City, Tennessee |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1235233933 | NPI | - | NPPES |
| 12900 | Other | UBH HEALTHPLAN | |
| 12900 | Other | UBH JOHN DEERE | |
| 3070480 | Other | MAGELLAN NAVIGATOR | |
| 620582605 | Other | INITIAL GROUP GROUP | |
| 010149428 | Other | VIRGINIA MEDICAID CTC | |
| 1047963 | Other | CIGNA MCC | |
| 250190 | Other | ANTHEM PROF TRIGON | |
| 334969 | Other | VALUEOPTIONS GROUP | |
| 620582605 | Other | CARITEN PHP HMO | |
| 3070480 | Other | MAGELLAN SUMMIT | |
| 010149339 | Other | VIRGINIA MEDICAID WATAUGA | |
| 12900 | Other | UBH SENIOR | |
| 620582605 | Other | CARITEN PHP POS | |
| 12900 | Other | UBH EMPLOYER | |
| 620582605 | Other | CARITEN PHP PPO | |
| 250190 | Other | ANTHEM PREF TRIGON | |
| 620582605 | Other | CARITEN PHP WORKCO | |
| 620582605 | Other | BEECH STREET |
| Mailing Address | Practice Location Address |
|---|---|
| Harry Lee Spurling, MA LMFT LPCMHSP LSPE 1167 Spratlin Park Dr, Gray, TN 37615-6205 Ph: (423) 467-3600 | Harry Lee Spurling, MA LMFT LPCMHSP LSPE 109 W Watauga Ave, Johnson City, TN 37604 Ph: (423) 232-2700 |
News Archive
Sectra and Philips have completed an agreement whereby Philips will sell Sectra PACS in Japan under a joint branding policy. The agreement revitalizes a partnership that ended in 2005, by which Sectra and Philips combined were among the market leaders for PACS.
Researchers from Australia determined that pediatric liver transplant patients who received a single-dose of the H1N1 vaccine were not adequately protected against the virus compared to healthy children.
Athersys, Inc. announced today positive results from its phase I clinical trial of MultiStem®, its allogeneic cell therapy product, administered to individuals following acute myocardial infarction (AMI), more commonly referred to as a heart attack. The study results, based on four months of post-treatment patient data, demonstrate that MultiStem was well tolerated at all dose levels and also suggest improvement in heart function in treated patients.
Traditionally, honey bee research has focused on environmental stressors such as pesticides, pathogens and diseases. Now a research team led by entomologists at the University of California, Riverside has published a study that focuses on an anthropogenic pollutant: selenium (Se).
› Verified 9 days ago